Skip to main content
Market intelligence
DXCMHealthcare

Dexcom Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 15, 2026Nicholas AugustinosCorporate insiderSale8,089$84.04$679,769
Sep 15, 2026Michael Jon BrownEVP Chief Legal Compliance OffSale1,700$84.04$142,868
Sep 10, 2026Jereme M SylvainEVP, Chief Financal OfficerSale3,638$83.27$302,936